FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.